Research Ready Training
Advarra’s Research Ready Training simplifies complex topics with modern eLearning, ensuring compliance and minimizing resource use.
Site
Clinical Trial Technology Solutions for Sites
Our integrated portfolio of cloud-based standardized solutions was built in collaboration with the world’s leading research sites.
Institutional Review Board (IRB) Services for Federal Grants
Simplify federal grant submissions with Advarra’s expert IRB support, offering compliance guidance and oversight for both single and multisite studies.
Institutional Review Board (IRB) Services for International Research
Advarra reviews research in the U.S., Puerto Rico, Canada, and limited minimal risk research outside these regions.
Institutional Biosafety Committee (IBC) Services Info Sheet
Advarra’s IBC services offer rapid, flexible solutions for IBC review, especially critical for gene therapy and other high-stakes research.
Institutional Review Board (IRB) Services Info Sheet
Advarra’s Institutional Review Board (IRB) offers expert guidance, supporting more than 3,500 institutions, academic medical centers, and site networks.
Endpoint Adjudication Committee (EAC) Services Info Sheet
Secure independent evaluation and adjudication of complex clinical trial endpoints.
Canadian Institutional Review Board / Research Ethics Board Services
Leverage Advarra’s expertise in Canada as the only officially recognized IRB/REB, offering extensive site reach and top-notch research ethics services.
Single Institutional Review Board (sIRB) Services Info Sheet
As the research community’s preferred sIRB partner, we help you meet regulatory requirements with efficiency and transparency.
Early Phase Research Support
Advarra provides accelerated review timelines, specialized support, and intuitive technology tailored to early phase studies.
Advarra University and Training
Advarra University offers a vast catalog of engaging training solutions tailored to research professionals.
Gene Therapy Ready Site Network
Advarra’s GTR Site Network includes 1,500+ vetted sites worldwide, fully prepared to support clinical trials in genetic engineering and advanced therapies.